Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma

Fig. 2

SHP expression and associated pathways in DLBCL patients. A Immunohistochemistry against SHP-1 was represented and scored (negative, 1 +, 2 +, and 3 +) on the DLBCL tissue microarrays (200× magnification times). B Expression of SHP-1 transcripts in DLBCL subtypes from Gene Expression Omnibus database were analyzed. C Whole-cell extracts of ABC DLBCL (U2932) and GCB DLBCL (OCI-Ly7, SU-DHL-6, and DB) cells were analyzed by Western blot analysis. D GSEA results showing the top 7 positive enrichment terms of the KEGG pathway gene sets

Back to article page